Global Adrenocortical Carcinoma Treatment Market, By Type (Localized Adrenocortical Carcinoma, Metastatic Adrenocortical Carcinoma), Drug Type (Tamoxifen, Mifepristone, Toremifene, Spironolactone, Others), Treatment (Surgery, Chemotherapy, Targeted Therapy, Radiation Therapy, Biologic Therapy, Others), Diagnosis (MRI, CT Scan, PET Scan, Biopsy, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.